Angle plc (AGL) Ordinary 10p
0.25p
(1.96%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.25p
(1.96%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.25p
(1.96%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
12.75p
13.15p
24.50p
£41.93 million
12.75p
12.73p
7.25p
n/a
0.50p (4.08%) Previous:
0.50p
228,560
n/a
30,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2023 | 31/12/2022 |
|---|---|---|
| Revenue (£m) | 2.19 | 1.04 |
| Profit before tax (£m) | (21.63) | (24.44) |
| Adjusted EPS (p): | (7.72) | (8.96) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Angle's Parsortix system used in 'breakthrough' breast cancer research
24 January 2025 10:51
-
Berenberg slashes target price on Angle
23 January 2025 11:21
-
Angle signs new agreement US biotech Recursion
19 September 2024 12:40
-
Novel findings using Parsortix
6 February 2025 07:00
-
Analysis of CTC-DNA and ctDNA using Illumina assay
29 January 2025 07:00
-
Parsortix used in research paper from ETH Zurich
24 January 2025 10:05
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.